Michael Déjean (President)
Michaël, a former rowing top athlete, is a recognized and well-known business leader who has a sense of communication, a quality essential to convince partners and collaborators.
Delphine Déjean (Secretary)
Delphine has been a general practitioner for more than 10 years and will allow the project to keep the reality of the field at every stage.
Bernadette Déjean (Treasurer)
Bernadette, a rare disease sufferer and patient advocate, combines the experience of the disease and the qualities of an outstanding manager.
Emilie Déjean (Honorary member)
Emilie decided to resign her position as a researcher in a large pharmaceutical laboratory to dedicate 100% of her time to this project. Thanks to 10 years at university (PharmD, PhD) and almost 10 years in major pharmaceutical groups (Roche, Novartis, Bristol-Myers-Squibb), she is convinced that this project can lead to a very effective treatment to slow or stop neurological diseases.